{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:39:08Z","timestamp":1792604348149,"version":"4.5.0"},"publisher-location":"Cham","reference-count":247,"publisher":"Springer Nature Switzerland","isbn-type":[{"value":"9783032294364","type":"print"},{"value":"9783032294371","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-3-032-29437-1_40","type":"book-chapter","created":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:51:55Z","timestamp":1792601515000},"page":"639-678","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Glycomics Meets Oncology: The Role of Mass Spectrometry in Cancer Research"],"prefix":"10.1007","author":[{"given":"Raluca","family":"Ica","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Roxana","family":"Biricioiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirela","family":"Sarbu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina D.","family":"Zamfir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2027,1,23]]},"reference":[{"key":"40_CR1","doi-asserted-by":"crossref","unstructured":"Varki A (2017) Biological roles of glycans. Glycobiology 27(1):3\u201349","DOI":"10.1093\/glycob\/cww086"},{"issue":"8","key":"40_CR2","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1042\/BCJ20180103","volume":"477","author":"GE Cervoni","year":"2020","unstructured":"Cervoni GE, Cheng JJ, Stackhouse KA, Heimburg-Molinaro J, Cummings RD (2020) O-glycan recognition and function in mice and human cancers. Biochem J 477(8):1541\u20131564","journal-title":"Biochem J"},{"issue":"7","key":"40_CR3","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1111\/j.1349-7006.2008.00839.x","volume":"99","author":"YY Zhao","year":"2008","unstructured":"Zhao YY, Takahashi M, Gu JG, Miyoshi E, Matsumoto A, Kitazume S et al. (2008) Functional roles of N-glycans in cell signaling and cell adhesion in cancer. Cancer Sci 99(7):1304\u20131310","journal-title":"Cancer Sci"},{"key":"40_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-3-030-70115-4_1","volume":"1325","author":"T Hirata","year":"2021","unstructured":"Hirata T, Kizuka Y (2021) N-Glycosylation. Adv Experim Med Biol 1325:3\u201324","journal-title":"Adv Experim Med Biol"},{"issue":"12","key":"40_CR5","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.3390\/cells9122652","volume":"9","author":"A Frappaolo","year":"2020","unstructured":"Frappaolo A, Karimpour-Ghahnavieh A, Sechi S, Giansanti MG (2020) The close relationship between the Golgi trafficking machinery and protein glycosylation. Cells 9(12):2652","journal-title":"Cells"},{"issue":"1","key":"40_CR6","doi-asserted-by":"publisher","first-page":"188464","DOI":"10.1016\/j.bbcan.2020.188464","volume":"1875","author":"D Thomas","year":"2021","unstructured":"Thomas D, Rathinavel AK, Radhakrishnan P (2021) Altered glycosylation in cancer: a promising target for biomarkers and therapeutics. Biochim Biophys Acta Rev Cancer 1875(1):188464","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"9","key":"40_CR7","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nrc3982","volume":"15","author":"SS Pinho","year":"2015","unstructured":"Pinho SS, Reis CA (2015) Glycosylation in cancer: mechanisms and clinical implications. Nature Reviews Cancer 15(9):540\u2013555","journal-title":"Nature Reviews Cancer"},{"key":"40_CR8","doi-asserted-by":"crossref","unstructured":"Duarte HO, Reis CA, Blanchard V, Tauber R (2025) Glycosylation in cancer. Handbook of experimental pharmacology vol 288, pp 243\u2013293","DOI":"10.1007\/164_2025_751"},{"issue":"1","key":"40_CR9","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41392-024-01886-1","volume":"9","author":"M He","year":"2024","unstructured":"He M, Zhou X, Wang X (2024) Glycosylation: mechanisms, biological functions and clinical implications. Signal Transduct Target Ther 9(1):194","journal-title":"Signal Transduct Target Ther"},{"issue":"11","key":"40_CR10","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1002\/cac2.12610","volume":"44","author":"X Xu","year":"2024","unstructured":"Xu X, Peng Q, Jiang X, Tan S, Yang W, Han Y et al. (2024) Altered glycosylation in cancer: molecular functions and therapeutic potential. Cancer Commun 44(11):1316\u20131336","journal-title":"Cancer Commun"},{"issue":"1","key":"40_CR11","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41416-020-01126-7","volume":"124","author":"C Dobie","year":"2021","unstructured":"Dobie C, Skropeta D (2021) Insights into the role of sialylation in cancer progression and metastasis. British J Cancer 124(1):76\u201390","journal-title":"British J Cancer"},{"issue":"6","key":"40_CR12","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3390\/cancers10060207","volume":"10","author":"E Rodrigues","year":"2018","unstructured":"Rodrigues E, Macauley MS (2018) Hypersialylation in cancer: modulation of inflammation and therapeutic opportunities. Cancers 10(6):207","journal-title":"Cancers"},{"key":"40_CR13","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3389\/fonc.2014.00028","volume":"4","author":"I H\u00e4uselmann","year":"2014","unstructured":"H\u00e4uselmann I, Borsig L (2014) Altered tumor-cell glycosylation promotes metastasis. Front Oncol 4:28","journal-title":"Front Oncol"},{"issue":"2","key":"40_CR14","doi-asserted-by":"publisher","first-page":"188409","DOI":"10.1016\/j.bbcan.2020.188409","volume":"1875","author":"G Luo","year":"2021","unstructured":"Luo G, Jin K, Deng S, Cheng H, Fan Z, Gong Y et al. (2021) Roles of CA19-9 in pancreatic cancer: biomarker, predictor and promoter. Biochim Biophys Acta Rev Cancer 1875(2):188409","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"40_CR15","doi-asserted-by":"publisher","first-page":"3177","DOI":"10.3390\/diagnostics12123177","volume":"12","author":"H Shen","year":"2022","unstructured":"Shen H, Lee C-Y, Chen C-H (2022) Protein glycosylation as biomarkers in gynecologic cancers. Diagnostics 12:3177","journal-title":"Diagnostics"},{"issue":"4","key":"40_CR16","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1093\/clinchem\/47.4.624","volume":"47","author":"MJ Duffy","year":"2001","unstructured":"Duffy MJ (2001) Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful?. Clinical Chem 47(4):624\u2013630","journal-title":"Clinical Chem"},{"issue":"3","key":"40_CR17","doi-asserted-by":"publisher","first-page":"659","DOI":"10.4251\/wjgo.v16.i3.659","volume":"16","author":"YR Wen","year":"2024","unstructured":"Wen YR, Lin XW, Zhou YW, Xu L, Zhang JL, Chen CY et al. (2024) N-glycan biosignatures as a potential diagnostic biomarker for early-stage pancreatic cancer. World J Gastrointest Oncol 16(3):659\u2013669","journal-title":"World J Gastrointest Oncol"},{"issue":"1","key":"40_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12014-024-09516-2","volume":"21","author":"S Liu","year":"2024","unstructured":"Liu S, Huang J, Liu Y, Lin J, Zhang H, Cheng L et al. (2024) Identification of serum N-glycan signatures in three major gastrointestinal cancers by high-throughput N-glycome profiling. Clin Proteomics 21(1):64","journal-title":"Clin Proteomics"},{"key":"40_CR19","doi-asserted-by":"publisher","first-page":"108149","DOI":"10.1016\/j.biotechadv.2023.108149","volume":"66","author":"R Bangarh","year":"2023","unstructured":"Bangarh R, Khatana C, Kaur S, Sharma A, Kaushal A, Siwal SS et al. (2023) Aberrant protein glycosylation: implications on diagnosis and immunotherapy. Biotechnol Adv  66:108149","journal-title":"Biotechnol Adv"},{"issue":"3","key":"40_CR20","doi-asserted-by":"publisher","first-page":"645","DOI":"10.3390\/cancers14030645","volume":"14","author":"N Berois","year":"2022","unstructured":"Berois N, Pittini A, Osinaga E (2022) Targeting tumor glycans for cancer therapy: successes, limitations, and perspectives. Cancers 14(3):645","journal-title":"Cancers"},{"issue":"2","key":"40_CR21","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1002\/mas.21713","volume":"42","author":"W Peng","year":"2023","unstructured":"Peng W, Gutierrez Reyes CD, Gautam S, Yu A, Cho BG, Goli M et al. (2023) MS-based glycomics and glycoproteomics methods enabling isomeric characterization. Mass Spectrom Rev 42(2):577\u2013616","journal-title":"Mass Spectrom Rev"},{"issue":"24","key":"40_CR22","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1002\/elps.201800273","volume":"39","author":"X Dong","year":"2018","unstructured":"Dong X, Huang Y, Cho BG, Zhong J, Gautam S, Peng W et al. (2018) Advances in mass spectrometry-based glycomics. Electrophoresis 39(24):3063\u20133081","journal-title":"Electrophoresis"},{"issue":"7","key":"40_CR23","doi-asserted-by":"publisher","first-page":"3040","DOI":"10.1021\/ac3000573","volume":"84","author":"N Leymarie","year":"2012","unstructured":"Leymarie N, Zaia J (2012) Effective use of mass spectrometry for glycan and glycopeptide structural analysis. Anal Chem 84(7):3040\u20133048","journal-title":"Anal Chem"},{"key":"40_CR24","doi-asserted-by":"crossref","unstructured":"Wilm M, Mann M (1996) Analytical properties of the nanoelectrospray ion source. Anal Chem 68(1):1\u20138","DOI":"10.1021\/ac9509519"},{"issue":"1","key":"40_CR25","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s10719-012-9376-3","volume":"30","author":"M Wuhrer","year":"2013","unstructured":"Wuhrer M (2013) Glycomics using mass spectrometry. GlycoconjJ 30(1):11\u201322","journal-title":"GlycoconjJ"},{"issue":"12","key":"40_CR26","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1002\/1522-2683(200107)22:12<2448::AID-ELPS2448>3.0.CO;2-A","volume":"22","author":"AD Zamfir","year":"2001","unstructured":"Zamfir AD, Peter-Katalinic J (2001) Glycoscreening by on-line sheathless capillary electrophoresis\/electrospray ionization-quadrupole time of flight-tandem mass spectrometry. Electrophoresis 22(12):2448\u20132457","journal-title":"Electrophoresis"},{"issue":"7","key":"40_CR27","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1021\/ac035320q","volume":"76","author":"A Zamfir","year":"2004","unstructured":"Zamfir A, Vakhrushev S, Sterling A, Niebel HJ, Allen M, Peter-Katalini\u0107 J (2004) Fully automated chip-based mass spectrometry for complex carbohydrate system analysis. Anal Chem 76(7):2046\u20132054","journal-title":"Anal Chem"},{"issue":"3","key":"40_CR28","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1039\/b413282c","volume":"5","author":"AD Zamfir","year":"2005","unstructured":"Zamfir AD, Lion N, Vukelic Z, Bindila L, Rossier J, Girault HH et al. (2005) Thin chip microsprayer system coupled to quadrupole time-of-flight mass spectrometer for glycoconjugate analysis. Lab Chip 5(3):298\u2013307","journal-title":"Lab Chip"},{"issue":"2","key":"40_CR29","first-page":"72","volume":"13","author":"CK Van Pelt","year":"2002","unstructured":"Van Pelt CK, Zhang S, Henion JD (2002) Characterization of a fully automated nanoelectrospray system with mass spectrometric detection for proteomic analyses. J Biomol Tech 13(2):72\u201384","journal-title":"J Biomol Tech"},{"issue":"11","key":"40_CR30","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1039\/b910917j","volume":"134","author":"M Prudent","year":"2009","unstructured":"Prudent M, Girault HH (2009) Functional electrospray emitters. Analyst 134(11):2189\u20132203","journal-title":"Analyst"},{"issue":"12","key":"40_CR31","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1007\/s13361-011-0250-5","volume":"22","author":"AD Zamfir","year":"2011","unstructured":"Zamfir AD, Serb A, Vukelic \u017d, Flangea CD, Schiopu C, Fabris D et al. (2011) Assessment of molecular expression and structure of gangliosides in brain metastasis of lung adenocarcinoma by an advanced approach based on fully automated chip-nanoelectrospray mass spectrometry. J Am Soc Mass Spectrom 22(12):2145\u20132159","journal-title":"J Am Soc Mass Spectrom"},{"issue":"8","key":"40_CR32","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1016\/j.bbagen.2016.02.003","volume":"1860","author":"CJ Gray","year":"2016","unstructured":"Gray CJ, Thomas B, Upton R, Migas LG, Eyers CE, Barran PE et al. (2016) Applications of ion mobility mass spectrometry for high throughput, high resolution glycan analysis. Biochim Biophys Acta 1860(8):1688\u20131709","journal-title":"Biochim Biophys Acta"},{"key":"40_CR33","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.cbpa.2017.11.020","volume":"42","author":"KA Morrison","year":"2018","unstructured":"Morrison KA, Clowers BH (2018) Contemporary glycomic approaches using ion mobility\u2013mass spectrometry. Curr Opin Chem Biol 42:119\u2013129","journal-title":"Curr Opin Chem Biol"},{"key":"40_CR34","doi-asserted-by":"crossref","unstructured":"Bechtella L, Chunsheng J, Fentker K, Ert\u00fcrk G R, Safferthal M, Polewski \u0141, et al (2024) Ion mobility\u2013tandem mass spectrometry of mucin-type O-glycans. Nature Commun 15(1):2611.","DOI":"10.1038\/s41467-024-46825-4"},{"key":"40_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cbpa.2017.10.007","volume":"42","author":"Z Chen","year":"2018","unstructured":"Chen Z, Glover MS, Li L (2018) Recent advances in ion mobility\u2013mass spectrometry for improved structural characterization of glycans and glycoconjugates. Curr Opin Chem Biol 42:1\u20138","journal-title":"Curr Opin Chem Biol"},{"key":"40_CR36","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/978-1-0716-0030-6_13","volume":"2084","author":"WB Struwe","year":"2020","unstructured":"Struwe WB, Harvey DJ (2020) Ion mobility\u2013mass spectrometry of glycoconjugates. Methods Mol Biol 2084:203\u2013219","journal-title":"Ion mobility\u2013mass spectrometry of glycoconjugates. Methods Mol Biol"},{"key":"40_CR37","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.biochi.2020.08.011","volume":"177","author":"M Sarbu","year":"2020","unstructured":"Sarbu M, Clemmer DE, Zamfir AD (2020) Ion mobility mass spectrometry of human melanoma gangliosides. Biochimie 177:226\u2013237","journal-title":"Biochimie"},{"issue":"17","key":"40_CR38","doi-asserted-by":"publisher","first-page":"8433","DOI":"10.3390\/ijms26178433","volume":"26","author":"R Ica","year":"2025","unstructured":"Ica R, Sarbu M, Biricioiu R, Fabris D, Vukeli\u0107 \u017d, Zamfir AD (2025) Novel application of ion mobility mass spectrometry reveals complex ganglioside landscape in diffuse astrocytoma peritumoral regions. Int J Mol Sci 26(17):8433","journal-title":"Int J Mol Sci"},{"key":"40_CR39","doi-asserted-by":"crossref","unstructured":"Opdenakker G, Rudd PM, Ponting CP, Dwek RA (1993) Concepts and principles of glycobiology. FASEB J 7(14):1330\u20131337","DOI":"10.1096\/fasebj.7.14.8224606"},{"issue":"9","key":"40_CR40","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1093\/glycob\/cwz045","volume":"29","author":"S Neelamegham","year":"2019","unstructured":"Neelamegham S, Aoki-Kinoshita K, Bolton E, Frank M, Lisacek F, L\u00fctteke T et al. (2019) Updates to the symbol nomenclature for glycans guidelines. Glycobiology 29(9):620\u2013624","journal-title":"Glycobiology"},{"issue":"7","key":"40_CR41","doi-asserted-by":"publisher","first-page":"e13855","DOI":"10.1111\/acel.13855","volume":"22","author":"J Fan","year":"2023","unstructured":"Fan J, Sha J, Chang S, Zhao H, Niu X, Gu Y et al. (2023) Generalized low levels of serum N-glycans associate with better health status. Aging Cell 22(7):e13855","journal-title":"Aging Cell"},{"key":"40_CR42","doi-asserted-by":"publisher","first-page":"957","DOI":"10.3389\/fonc.2020.00957","volume":"10","author":"Y Jian","year":"2020","unstructured":"Jian Y, Xu Z, Xu C, Zhang L, Sun X, Yang D et al. (2020) The roles of glycans in bladder cancer. Front Oncol 10:957","journal-title":"Front Oncol"},{"issue":"1","key":"40_CR43","doi-asserted-by":"publisher","first-page":"79","DOI":"10.2337\/dc17-1042","volume":"41","author":"ML Bermingham","year":"2018","unstructured":"Bermingham ML, Colombo M, McGurnaghan SJ, Blackbourn LAK, Vu\u010dkovi\u0107 F, Pu\u010di\u0107 Bakovi\u0107 M et al. (2018) N-glycan profile and kidney disease in type 1 diabetes. Diabetes Care 41(1):79\u201387","journal-title":"Diabetes Care"},{"issue":"10","key":"40_CR44","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/nri3737","volume":"14","author":"MS Macauley","year":"2014","unstructured":"Macauley MS, Crocker PR, Paulson JC (2014) Siglec-mediated regulation of immune cell function in disease. Nature Rev Immunol 14(10):653\u2013666","journal-title":"Nature Rev Immunol"},{"issue":"1","key":"40_CR45","first-page":"238","volume":"1846","author":"C B\u00fcll","year":"2014","unstructured":"B\u00fcll C, den Brok MH, Adema GJ (2014) Sweet escape: Sialic acids in tumor immune evasion. Biochim Biophys Acta 1846(1):238\u2013246","journal-title":"Biochim Biophys Acta"},{"key":"40_CR46","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1146\/annurev-pathol-012414-040438","volume":"10","author":"SR Stowell","year":"2015","unstructured":"Stowell SR, Ju T, Cummings RD (2015) Protein glycosylation in cancer. Ann Rev Pathol 10:473\u2013510","journal-title":"Ann Rev Pathol"},{"issue":"10","key":"40_CR47","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1093\/glycob\/cwn071","volume":"18","author":"KS Lau","year":"2008","unstructured":"Lau KS, Dennis JW (2008) N-Glycans in cancer progression. Glycobiology 18(10):750\u2013760","journal-title":"Glycobiology"},{"issue":"1","key":"40_CR48","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ccell.2019.06.006","volume":"36","author":"S Mereiter","year":"2019","unstructured":"Mereiter S, Balma\u00f1a M, Campos D, Gomes J, Reis CA (2019) Glycosylation in the era of cancer-targeted therapy: where are we heading?. Cancer Cell 36(1):6\u201316","journal-title":"Cancer Cell"},{"issue":"6","key":"40_CR49","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1021\/pr900092r","volume":"8","author":"Y Misonou","year":"2009","unstructured":"Misonou Y, Shida K, Korekane H, Seki Y, Noura S, Ohue M et al. (2009) Comprehensive clinico-glycomic study of 16 colorectal cancer specimens: elucidation of aberrant glycosylation and its mechanistic causes in colorectal cancer cells. J Proteome Res 8(6):2990\u20133005","journal-title":"J Proteome Res"},{"issue":"4","key":"40_CR50","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1136\/jcp.2009.071035","volume":"63","author":"CA Reis","year":"2010","unstructured":"Reis CA, Osorio H, Silva L, Gomes C, David L (2010) Alterations in glycosylation as biomarkers for cancer detection. J Clin Pathol 63(4):322\u2013329","journal-title":"J Clin Pathol"},{"issue":"1","key":"40_CR51","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/elps.201800238","volume":"40","author":"D Josic","year":"2019","unstructured":"Josic D, Martinovic T, Pavelic K (2019) Glycosylation and metastases. Electrophoresis 40(1):140\u2013150","journal-title":"Electrophoresis"},{"issue":"7","key":"40_CR52","doi-asserted-by":"publisher","first-page":"770","DOI":"10.3390\/biomedicines9070770","volume":"9","author":"M Pucci","year":"2021","unstructured":"Pucci M, Malagolini N, Dall\u2019Olio F (2021) Glycobiology of the epithelial to mesenchymal transition. Biomedicines 9(7):770","journal-title":"Biomedicines"},{"issue":"19","key":"40_CR53","doi-asserted-by":"publisher","first-page":"12435","DOI":"10.1021\/acs.analchem.9b03074","volume":"91","author":"WQ Cao","year":"2019","unstructured":"Cao WQ, Jiang BY, Huang JM, Zhang L, Liu MQ, Yao J et al. (2019) Straightforward and highly efficient strategy for hepatocellular carcinoma glycoprotein biomarker discovery using a nonglycopeptide mass spectrometry pipeline. Anal Chem 91(19):12435\u201312443","journal-title":"Anal Chem"},{"issue":"10","key":"40_CR54","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1021\/acs.accounts.6b00193","volume":"49","author":"MK Sethi","year":"2016","unstructured":"Sethi MK, Hancock WS, Fanayan S (2016) Identifying N-glycan biomarkers in colorectal cancer by mass spectrometry. Acc Chem Res 49(10):2099\u20132106","journal-title":"Acc Chem Res"},{"issue":"5","key":"40_CR55","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1093\/glycob\/cwz005","volume":"29","author":"D Zhang","year":"2019","unstructured":"Zhang D, Xie Q, Wang Q, Wang Y, Miao J, Li L et al. (2019) Mass spectrometry analysis reveals aberrant N-glycans in colorectal cancer tissues. Glycobiology 29(5):372\u2013384","journal-title":"Glycobiology"},{"issue":"4","key":"40_CR56","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1021\/acs.jproteome.3c00833","volume":"23","author":"R L\u00f3pez-Cort\u00e9s","year":"2024","unstructured":"L\u00f3pez-Cort\u00e9s R, Muinelo-Romay L, Fern\u00e1ndez-Briera A, Gil Mart\u00edn E (2024) High-throughput mass spectrometry analysis of N-glycans and protein markers after FUT8 knockdown in the syngeneic SW480\/SW620 colorectal cancer cell model. J Proteome Res 23(4):1379\u20131398","journal-title":"J Proteome Res"},{"key":"40_CR57","doi-asserted-by":"publisher","first-page":"100012","DOI":"10.1074\/mcp.RA120.002256","volume":"20","author":"CT McDowell","year":"2021","unstructured":"McDowell CT, Klamer Z, Hall J, West CA, Wisniewski L, Powers TW et al. (2021) Imaging mass spectrometry and lectin analysis of N-linked glycans in carbohydrate antigen-defined pancreatic cancer tissues. Mol Cell Proteomics 20:100012","journal-title":"Mol Cell Proteomics"},{"issue":"13","key":"40_CR58","doi-asserted-by":"publisher","first-page":"5086","DOI":"10.1021\/acs.analchem.3c04045","volume":"96","author":"T \u010caval","year":"2024","unstructured":"\u010caval T, Xu G, Baniasad M, Chu CW, Rice R, Hundal I et al. (2024) Mass spectrometry analysis of glycopeptides enriched by anion exchange-mediated methods reveals PolyLacNAc-extended N-Glycans in integrins and tetraspanins in melanoma cells. Anal Chem 96(13):5086\u20135094","journal-title":"Anal Chem"},{"issue":"7","key":"40_CR59","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1074\/mcp.M114.038273","volume":"13","author":"Y Liu","year":"2014","unstructured":"Liu Y, Chen J, Sethi A, Li QK, Chen L, Collins B et al. (2014) Glycoproteomic analysis of prostate cancer tissues by SWATH mass spectrometry discovers N-acylethanolamine acid amidase and protein tyrosine kinase 7 as signatures for tumor aggressiveness. Mol Cell Proteomics 13(7):1753\u20131768","journal-title":"Mol Cell Proteomics"},{"issue":"21\u201322","key":"40_CR60","doi-asserted-by":"publisher","first-page":"e1800482","DOI":"10.1002\/pmic.201800482","volume":"19","author":"MT Briggs","year":"2019","unstructured":"Briggs MT, Condina MR, Ho YY, Everest-Dass AV, Mittal P, Kaur G et al. (2019) MALDI mass spectrometry imaging of early- and late-stage serous ovarian cancer tissue reveals stage-specific N-glycans. Proteomics 19(21\u201322):e1800482","journal-title":"Proteomics"},{"issue":"1","key":"40_CR61","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1021\/acs.analchem.7b04202","volume":"90","author":"MJ Kailemia","year":"2018","unstructured":"Kailemia MJ, Xu G, Wong M, Li Q, Goonatilleke E, Leon F et al. (2018) Recent advances in mass spectrometry methods for glycomics and cancer. Anal Chem 90(1):208\u2013224","journal-title":"Anal Chem"},{"key":"40_CR62","doi-asserted-by":"crossref","unstructured":"Tondepu C, Karumbaiah L (2022) Glycomaterials to investigate the functional role of aberrant glycosylation in glioblastoma. Adv Healthc Mater 11(4):e2101956","DOI":"10.1002\/adhm.202101956"},{"issue":"2","key":"40_CR63","doi-asserted-by":"publisher","first-page":"446","DOI":"10.3390\/cells9020446","volume":"9","author":"R Gupta","year":"2020","unstructured":"Gupta R, Leon F, Rauth S, Batra SK, Ponnusamy MP (2020) A systematic review on the implications of O-linked glycan branching and truncating enzymes on cancer progression and metastasis. Cells 9(2):446","journal-title":"Cells"},{"issue":"10","key":"40_CR64","doi-asserted-by":"publisher","first-page":"3890","DOI":"10.1021\/acs.jproteome.0c00435","volume":"19","author":"H Wilkinson","year":"2020","unstructured":"Wilkinson H, Saldova R (2020) Current methods for the characterization of O-glycans. J Proteome Res 19(10):3890\u20133905","journal-title":"J Proteome Res"},{"key":"40_CR65","unstructured":"Brockhausen I, Wandall H, Hagen KGT (2022) O-GalNAc glycans. In: Varki A et al (eds), Essentials of glycobiology, 4th edn. Cold Spring Harbor Laboratory Press."},{"key":"40_CR66","unstructured":"Brockhausen I, Schachter H, Stanley, P (2009) O-GalNAc glycans. In: Varki A et al (eds), Essentials of glycobiology, 2nd edn. Cold Spring Harbor Laboratory Press."},{"issue":"10","key":"40_CR67","doi-asserted-by":"publisher","first-page":"BSR20220094","DOI":"10.1042\/BSR20220094","volume":"42","author":"N Thompson","year":"2022","unstructured":"Thompson N, Wakarchuk W (2022) O-glycosylation and its role in therapeutic proteins. Bioscience Reports 42(10):BSR20220094","journal-title":"Bioscience Reports"},{"key":"40_CR68","unstructured":"Haltiwanger RS, Wells L, Freeze HH, Jafar-Nejad H, Okajima T, Stanley P (2022) Other Classes of Eukaryotic Glycans. In: Varki A, Cummings RD, Esko JD, Stanley P, Hart GW, Aebi M, Mohnen D, Kinoshita T, Packer NH, Prestegard JH, Schnaar RL, Seeberger PH (eds). Essentials of Glycobiology [Internet]. 4th edn. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press"},{"issue":"2","key":"40_CR69","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1021\/acsmeasuresciau.3c00071","volume":"4","author":"M Safferthal","year":"2024","unstructured":"Safferthal M, Bechtella L, Zappe A, Vos GM, Pagel K (2024) Labeling of mucin-type O-glycans for quantification using liquid chromatography and fluorescence detection. ACS Meas Sci Au 4(2):223\u2013230","journal-title":"ACS Meas Sci Au"},{"issue":"8","key":"40_CR70","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1016\/j.bbagen.2016.03.008","volume":"1860","author":"J Chia","year":"2016","unstructured":"Chia J, Goh G, Bard F (2016) Short O-GalNAc glycans: regulation and role in tumor development and clinical perspectives. Biochim Biophys Acta 1860(8):1623\u20131639","journal-title":"Biochim Biophys Acta"},{"key":"40_CR71","doi-asserted-by":"publisher","first-page":"109214","DOI":"10.1016\/j.yebeh.2023.109214","volume":"142","author":"HF Lee","year":"2023","unstructured":"Lee HF, Chi CS (2023) Congenital disorders of glycosylation and infantile epilepsy. Epilepsy Behavior 142:109214","journal-title":"Epilepsy Behavior"},{"issue":"1","key":"40_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-023-02446-x","volume":"13","author":"P Pradeep","year":"2023","unstructured":"Pradeep P, Kang H, Lee B (2023) Glycosylation and behavioral symptoms in neurological disorders. Transl Psychiatry 13(1):154","journal-title":"Transl Psychiatry"},{"issue":"1","key":"40_CR73","doi-asserted-by":"publisher","DOI":"10.1186\/s13104-023-06314-1","volume":"16","author":"S Sabry","year":"2023","unstructured":"Sabry S, Eissa NR, Zaki MS (2023) Abnormal expression of lysosomal glycoproteins in patients with congenital disorders of glycosylation. BMC Res Notes 16(1):53","journal-title":"BMC Res Notes"},{"issue":"8","key":"40_CR74","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/s41569-024-00998-z","volume":"21","author":"JC Chatham","year":"2024","unstructured":"Chatham JC, Patel RP (2024) Protein glycosylation in cardiovascular health and disease. Nat Rev Cardiol 21(8):525\u2013544","journal-title":"Nat Rev Cardiol"},{"key":"40_CR75","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/978-3-030-70115-4_15","volume":"1325","author":"H Dashti","year":"2021","unstructured":"Dashti H, Pabon Porras MA, Mora S (2021) Glycosylation and cardiovascular diseases. Adv Exp Med Biol 1325:307\u2013319","journal-title":"Adv Exp Med Biol"},{"key":"40_CR76","doi-asserted-by":"publisher","first-page":"625348","DOI":"10.3389\/fnins.2020.625348","volume":"14","author":"H Haukedal","year":"2020","unstructured":"Haukedal H, Freude KK (2020) Implications of glycosylation in Alzheimer\u2019s disease. Front Neurosci 14:625348","journal-title":"Front Neurosci"},{"issue":"12","key":"40_CR77","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/nchembio.1403","volume":"9","author":"MA Wolfert","year":"2013","unstructured":"Wolfert MA, Boons GJ (2013) Adaptive immune activation: glycosylation does matter. Nat Chem Biol 9(12):776\u2013784","journal-title":"Nat Chem Biol"},{"issue":"9","key":"40_CR78","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/s41579-022-00712-1","volume":"20","author":"JF Wardman","year":"2022","unstructured":"Wardman JF, Bains RK, Rahfeld P, Withers SG (2022) Carbohydrate-active enzymes (CAZymes) in the gut microbiome. Nat Rev Microbiol 20(9):542\u2013556","journal-title":"Nat Rev Microbiol"},{"issue":"6","key":"40_CR79","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/s41581-019-0129-4","volume":"15","author":"C Reily","year":"2019","unstructured":"Reily C, Stewart TJ, Renfrow MB, Novak J (2019) Glycosylation in health and disease. Nat Rev Nephrol 15(6):346\u2013366","journal-title":"Nat Rev Nephrol"},{"key":"40_CR80","doi-asserted-by":"publisher","first-page":"153303382211488","DOI":"10.1177\/15330338221148811","volume":"22","author":"EH Doud","year":"2023","unstructured":"Doud EH, Yeh ES (2023) Mass spectrometry\u2013based glycoproteomic workflows for cancer biomarker discovery. Technol Cancer Res Treat 22:15330338221148811","journal-title":"Technol Cancer Res Treat"},{"issue":"4","key":"40_CR81","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1042\/BST20170483","volume":"46","author":"JM Burchell","year":"2018","unstructured":"Burchell JM, Beatson R, Graham R, Taylor-Papadimitriou J, Tajadura-Ortega V (2018) O-linked mucin-type glycosylation in breast cancer. Biochem Soc Transact 46(4):779\u2013788","journal-title":"Biochem Soc Transact"},{"key":"40_CR82","volume-title":"Small molecules for cancer treatment","author":"SD Majumder","year":"2024","unstructured":"Majumder SD, Agarwal S, Vasishth K, Kaur N, Bose S (2024) Therapeutic relevance of glycosylation inhibitors in cancer. In: Pathak S, Banerjee A, Duttaroy AK (Eds.)Eds. Small molecules for cancer treatment. Springer"},{"issue":"13","key":"40_CR83","doi-asserted-by":"publisher","first-page":"3266","DOI":"10.3390\/cancers15133266","volume":"15","author":"D Pinto","year":"2023","unstructured":"Pinto D, Parameswaran R (2023) Role of truncated O-GalNAc glycans in cancer progression and metastasis in endocrine cancers. Cancers 15(13):3266","journal-title":"Cancers"},{"issue":"39","key":"40_CR84","doi-asserted-by":"publisher","first-page":"E4066","DOI":"10.1073\/pnas.1406619111","volume":"111","author":"P Radhakrishnan","year":"2014","unstructured":"Radhakrishnan P, Dabelsteen S, Madsen FB, Francavilla C, Kopp KL, Steentoft C et al. (2014) Immature truncated O-glycophentotype of cancer directly induces oncogenic features. Proc Natl Acad Sci 111(39):E4066\u2013E4075","journal-title":"Proc Natl Acad Sci"},{"issue":"12","key":"40_CR85","doi-asserted-by":"publisher","first-page":"3265","DOI":"10.3390\/biomedicines10123265","volume":"10","author":"L Peric","year":"2022","unstructured":"Peric L, Vukadin S, Petrovic A, Kuna L, Puseljic N, Sikora R et al. (2022) Glycosylation alterations in cancer cells: prognostic value of glycan biomarkers and potential as novel therapeutic targets in breast cancer. Biomedicines 10(12):3265","journal-title":"Biomedicines"},{"key":"40_CR86","doi-asserted-by":"publisher","first-page":"123855","DOI":"10.1016\/j.ijbiomac.2023.123855","volume":"236","author":"X Chang","year":"2023","unstructured":"Chang X, Obianwuna UE, Wang J, Zhang H, Qi G, Qiu K et al. (2023) Glycosylated proteins with abnormal glycosylation changes are potential biomarkers in early diagnosis of breast cancer. Int J Biol Macromol 236:123855","journal-title":"Int J Biol Macromol"},{"issue":"7","key":"40_CR87","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1021\/pr060010k","volume":"5","author":"HJ An","year":"2006","unstructured":"An HJ, Miyamoto S, Lancaster KS, Kirmiz C, Li B, Lam KS et al. (2006) Profiling of glycans in serum for the discovery of potential biomarkers for ovarian cancer. J Proteome Res 5(7):1626\u20131635","journal-title":"J Proteome Res"},{"key":"40_CR88","doi-asserted-by":"publisher","DOI":"10.1186\/s12014-017-9137-1","volume":"14","author":"S Yang","year":"2017","unstructured":"Yang S, H\u00f6ti N, Yang W, Liu Y, Chen L, Li S et al. (2017) Simultaneous analysis of N-linked and O-linked glycans of ovarian cancer cells using a solid-phase chemoenzymatic method. Clin Proteomics 14: 3","journal-title":"Clin Proteomics"},{"key":"40_CR89","doi-asserted-by":"publisher","first-page":"1104936","DOI":"10.3389\/fonc.2023.1104936","volume":"13","author":"D Takakura","year":"2023","unstructured":"Takakura D, Ohashi S, Kobayashi N, Tokuhisa M, Ichikawa Y, Kawasaki N (2023) Targeted O-glycoproteomics for the development of diagnostic markers for advanced colorectal cancer. Front Oncol 13:1104936","journal-title":"Front Oncol"},{"issue":"22","key":"40_CR90","doi-asserted-by":"publisher","first-page":"5241","DOI":"10.3390\/molecules29225241","volume":"29","author":"M Wilczak","year":"2024","unstructured":"Wilczak M, Surman M, Przyby\u0142o M (2024) Towards understanding the role of the glycosylation of proteins present in extracellular vesicles in urinary tract diseases: contributions to cancer and beyond. Molecules 29(22):5241","journal-title":"Molecules"},{"key":"40_CR91","doi-asserted-by":"publisher","first-page":"809170","DOI":"10.3389\/fonc.2021.809170","volume":"11","author":"W Butler","year":"2021","unstructured":"Butler W, Huang J (2021) Glycosylation changes in prostate cancer progression. Front Oncol 11:809170","journal-title":"Front Oncol"},{"issue":"1","key":"40_CR92","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-50092-6","volume":"14","author":"Y Gao","year":"2024","unstructured":"Gao Y, Li W, Guo H, Hao Y, Lu L, Li J et al. (2024) Construction of an abnormal glycosylation risk model and its application in predicting the prognosis of patients with head and neck cancer. Scientific Rep 14(1):1310","journal-title":"Scientific Rep"},{"key":"40_CR93","doi-asserted-by":"publisher","first-page":"649338","DOI":"10.3389\/fonc.2021.649338","volume":"11","author":"T Khan","year":"2021","unstructured":"Khan T, Cabral H (2021) Abnormal glycosylation of cancer stem cells and targeting strategies. Front Oncol 11:649338","journal-title":"Front Oncol"},{"issue":"24","key":"40_CR94","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1038\/s41388-023-02702-w","volume":"42","author":"Y Wang","year":"2023","unstructured":"Wang Y, Chen H (2023) Protein glycosylation alterations in hepatocellular carcinoma: function and clinical implications. Oncogene 42(24):1970\u20131979","journal-title":"Oncogene"},{"issue":"22","key":"40_CR95","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.3390\/cells11223666","volume":"11","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Sun L, Lei C, Li W, Han J, Zhang J et al. (2022) A sweet warning: Mucin-type O-glycans in cancer. Cells 11(22):3666","journal-title":"Cells"},{"issue":"1","key":"40_CR96","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-023-00491-8","volume":"11","author":"J Yue","year":"2023","unstructured":"Yue J, Huang R, Lan Z, Xiao B, Luo Z (2023) Abnormal glycosylation in glioma: related changes in biology, biomarkers and targeted therapy. Biomark Res 11(1):54","journal-title":"Biomark Res"},{"issue":"23","key":"40_CR97","doi-asserted-by":"publisher","first-page":"8401","DOI":"10.3390\/app10238401","volume":"10","author":"M Muthu","year":"2020","unstructured":"Muthu M, Gopal J, Chun S, Devadoss AJP, Oh J-W (2020) Status quo of glycosylation in cancer: What is, what is not and what is to be. Appl Sci 10(23):8401","journal-title":"Appl Sci"},{"key":"40_CR98","doi-asserted-by":"publisher","first-page":"100964","DOI":"10.1016\/j.mam.2021.100964","volume":"79","author":"A Magalh\u00e3es","year":"2021","unstructured":"Magalh\u00e3es A, Duarte HO, Reis CA (2021) The role of O-glycosylation in human disease. Mol Aspects Med 79:100964","journal-title":"Mol Aspects Med"},{"issue":"Suppl. 2","key":"40_CR99","doi-asserted-by":"publisher","DOI":"10.1186\/bcr1913","volume":"10","author":"S Julien","year":"2008","unstructured":"Julien S, Coleman J, Picco G, Beatson R, Taylor-Papadimitriou J, Burchell J (2008) Understanding and exploiting changes in O-linked glycosylation in breast cancer. Breast Cancer Res 10(Suppl. 2):P29","journal-title":"Breast Cancer Res"},{"key":"40_CR100","doi-asserted-by":"publisher","first-page":"1292588","DOI":"10.3389\/fimmu.2024.1292588","volume":"15","author":"R Roy","year":"2024","unstructured":"Roy R (2024) Cancer cells and viruses share common glycoepitopes: exciting opportunities toward combined treatments. Front Immunol 15:1292588","journal-title":"Front Immunol"},{"issue":"17","key":"40_CR101","doi-asserted-by":"publisher","first-page":"7886","DOI":"10.1021\/acs.chemrev.7b00732","volume":"118","author":"LR Ruhaak","year":"2018","unstructured":"Ruhaak LR, Xu G, Li Q, Goonatilleke E, Lebrilla CB (2018) Mass spectrometry approaches to glycomic and glycoproteomic analyses. Chem Rev 118(17):7886\u20137930","journal-title":"Chem Rev"},{"key":"40_CR102","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.trac.2018.09.007","volume":"108","author":"KR Reiding","year":"2018","unstructured":"Reiding KR, Bondt A, Franc V, Heck AJR (2018) The benefits of hybrid fragmentation methods for glycoproteomics. Trends Anal Chem 108:260\u2013268","journal-title":"Trends Anal Chem"},{"key":"40_CR103","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/bs.mie.2016.11.009","volume":"585","author":"R Zhu","year":"2017","unstructured":"Zhu R, Zacharias L, Wooding KM, Peng W, Mechref Y (2017) Glycoprotein enrichment analytical techniques: advantages and disadvantages. Methods Enzymol 585:397\u2013429","journal-title":"Methods Enzymol"},{"key":"40_CR104","doi-asserted-by":"publisher","DOI":"10.1186\/1559-0275-11-14","volume":"11","author":"H Liu","year":"2014","unstructured":"Liu H, Zhang N, Wan D, Cui M, Liu Z, Liu S (2014) Mass spectrometry-based analysis of glycoproteins and its clinical applications in cancer biomarker discovery. Clin Proteomics 11: 14","journal-title":"Clin Proteomics"},{"issue":"2","key":"40_CR105","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1021\/acs.analchem.9b03753","volume":"92","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, Lih TM, Yang G, Chen SY, Chen L, Chan DW et al. (2020) An integrated workflow for global, glyco-, and phospho-proteomic analysis of tumor tissues. Anal Chem 92(2):1842\u20131849","journal-title":"Anal Chem"},{"key":"40_CR106","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.copbio.2021.07.006","volume":"71","author":"Y Xu","year":"2021","unstructured":"Xu Y, Zhang H (2021) Putting the pieces together: mapping the O-glycoproteome. Curr Opin Biotechnol 71:130\u2013136","journal-title":"Curr Opin Biotechnol"},{"key":"40_CR107","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.ab.2009.08.023","volume":"395","author":"J Wohlgemuth","year":"2009","unstructured":"Wohlgemuth J, Karas M, Eichhorn T, Hendriks R, Andrecht S (2009) Quantitative site-specific analysis of protein glycosylation by LC-MS using different glycopeptide-enrichment strategies. Anal Biochem 395:178\u2013188","journal-title":"Anal Biochem"},{"issue":"5","key":"40_CR108","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.sbi.2009.05.005","volume":"19","author":"SJ North","year":"2009","unstructured":"North SJ, Hitchen PG, Haslam SM, Dell A (2009) Mass spectrometry in the analysis of N- and O-linked glycans. Curr Opin Struct Biol 19(5):498\u2013506","journal-title":"Curr Opin Struct Biol"},{"issue":"9","key":"40_CR109","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.3390\/cells9091986","volume":"9","author":"A Illiano","year":"2020","unstructured":"Illiano A, Pinto G, Melchiorre C, Carpentieri A, Faraco V, Amoresano A (2020) Protein glycosylation investigated by mass spectrometry: an overview. Cells 9(9):1986","journal-title":"Cells"},{"issue":"36","key":"40_CR110","doi-asserted-by":"publisher","first-page":"e202303410","DOI":"10.1002\/anie.202303410","volume":"62","author":"J Liu","year":"2023","unstructured":"Liu J, Cheng B, Fan X, Zhou X, Wang J, Zhou W et al. (2023) Click-iG: simultaneous enrichment and profiling of intact N-linked, O-GalNAc, and O-GlcNAcylated glycopeptides. Angew Chem Int Ed 62(36):e202303410","journal-title":"Angew Chem Int Ed"},{"issue":"5","key":"40_CR111","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3390\/cells13050394","volume":"13","author":"A Helms","year":"2024","unstructured":"Helms A, Brodbelt JS (2024) Mass spectrometry strategies for O-glycoproteomics. Cells 13(5):394","journal-title":"Cells"},{"issue":"1","key":"40_CR112","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1002\/elps.201600357","volume":"38","author":"A Banazadeh","year":"2017","unstructured":"Banazadeh A, Veillon L, Wooding KM, Zabet-Moghaddam M, Mechref Y (2017) Recent advances in mass spectrometric analysis of glycoproteins. Electrophoresis 38(1):162\u2013189","journal-title":"Electrophoresis"},{"issue":"12","key":"40_CR113","doi-asserted-by":"publisher","first-page":"4829","DOI":"10.1021\/ac200493c","volume":"83","author":"FG Hanisch","year":"2011","unstructured":"Hanisch FG (2011) Top-down sequencing of O-glycoproteins by in-source decay matrix-assisted laser desorption ionization mass spectrometry for glycosylation site analysis. Anal Chem 83(12):4829\u20134837","journal-title":"Anal Chem"},{"issue":"5","key":"40_CR114","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1021\/pr400136p","volume":"12","author":"S Nicolardi","year":"2013","unstructured":"Nicolardi S, van der Burgt YE, Dragan I, Hensbergen PJ, Deelder AM (2013) Identification of new apolipoprotein-CIII glycoforms with ultrahigh-resolution MALDI-FTICR mass spectrometry of human sera. J Proteome Res 12(5):2260\u20132268","journal-title":"J Proteome Res"},{"issue":"1","key":"40_CR115","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1039\/C8RA07200K","volume":"9","author":"BB Pandeswari","year":"2019","unstructured":"Pandeswari BB, Sabareesh V (2019) Middle-down approach: a choice to sequence and characterize proteins\/proteomes by mass spectrometry. RSC Adv 9(1):313\u2013344","journal-title":"RSC Adv"},{"issue":"8","key":"40_CR116","doi-asserted-by":"publisher","first-page":"3286","DOI":"10.1021\/acs.jproteome.0c00218","volume":"19","author":"NM Riley","year":"2020","unstructured":"Riley NM, Malaker SA, Driessen MD, Bertozzi CR (2020) Optimal dissociation methods differ for N- and O-glycopeptides. J Proteome Res 19(8):3286\u20133301","journal-title":"J Proteome Res"},{"key":"40_CR117","doi-asserted-by":"publisher","first-page":"102174","DOI":"10.1016\/j.cbpa.2022.102174","volume":"69","author":"D Ince","year":"2022","unstructured":"Ince D, Lucas TM, Malaker SA (2022) Current strategies for characterization of mucin-domain glycoproteins. Curr Opin Chem Biol 69:102174","journal-title":"Curr Opin Chem Biol"},{"key":"40_CR118","unstructured":"Menon G, El-Nakeep S Babiker HM (2025) Gastric cancer. StatPearls. StatPearls Publishing."},{"issue":"2","key":"40_CR119","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/prca.201500041","volume":"10","author":"Y He","year":"2016","unstructured":"He Y, Xie Q, Wang Y, Liang Y, Xu X, Li Y et al. (2016) Liquid chromatography mass spectrometry-based O-glycomics to evaluate glycosylation alterations in gastric cancer. Proteomics Clin Appl 10(2):206\u2013215","journal-title":"Proteomics Clin Appl"},{"issue":"6","key":"40_CR120","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1074\/mcp.M114.046862","volume":"14","author":"D Campos","year":"2015","unstructured":"Campos D, Freitas D, Gomes J, Magalh\u00e3es A, Steentoft C, Gomes C et al. (2015) Probing the O-glycoproteome of gastric cancer cell lines for biomarkers. Mol Cell Proteomics 14(6):1616\u20131629","journal-title":"Mol Cell Proteomics"},{"issue":"52","key":"40_CR121","doi-asserted-by":"publisher","first-page":"87284","DOI":"10.18632\/oncotarget.13539","volume":"7","author":"X Li","year":"2016","unstructured":"Li X, Guan F, Li D, Tan Z, Yang G, Wu Y et al. (2016) Identification of aberrantly expressed glycans in gastric cancer via lectin microarray and mass spectrometry analyses. Oncotarget 7(52):87284\u201387300","journal-title":"Oncotarget"},{"issue":"23","key":"40_CR122","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.3748\/wjg.v19.i23.3573","volume":"19","author":"K Kodar","year":"2013","unstructured":"Kodar K, Izotova J, Klaamas K, Sergeyev B, J\u00e4rvek\u00fclg L, Kurtenkov O (2013) Aberrant glycosylation of anti-Thomsen\u2013Friedenreich glycotope immunoglobulin G in gastric cancer patients. World J Gastroenterol 19(23):3573\u20133582","journal-title":"World J Gastroenterol"},{"issue":"9822","key":"40_CR123","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/S0140-6736(11)61347-0","volume":"379","author":"A Forner","year":"2012","unstructured":"Forner A, Llovet JM, Bruix J (2012) Hepatocellular carcinoma. The Lancet 379(9822):1245\u20131255","journal-title":"The Lancet"},{"key":"40_CR124","doi-asserted-by":"publisher","first-page":"705341","DOI":"10.3389\/fchem.2021.705341","volume":"9","author":"H Shu","year":"2021","unstructured":"Shu H, Zhang L, Chen Y, Guo Y, Li L, Chen F et al. (2021) Quantification of intact O-glycopeptides on haptoglobin in sera of patients with hepatocellular carcinoma and liver cirrhosis. Front Chem 9:705341","journal-title":"Front Chem"},{"key":"40_CR125","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jprot.2016.09.004","volume":"153","author":"P Darebna","year":"2017","unstructured":"Darebna P, Novak P, Kucera R, Topolcan O, Sanda M, Goldman R et al. (2017) Changes in the expression of N- and O-glycopeptides in patients with colorectal cancer and hepatocellular carcinoma quantified by full-MS scan FT-ICR and multiple reaction monitoring. J Proteomics 153:44\u201352","journal-title":"J Proteomics"},{"issue":"2","key":"40_CR126","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1021\/pr800740j","volume":"8","author":"C Robbe-Masselot","year":"2009","unstructured":"Robbe-Masselot C, Herrmann A, Maes E, Carlstedt I, Michalski JC, Capon C (2009) Expression of a core 3 disialyl-Le(x) hexasaccharide in human colorectal cancers: a potential marker of malignant transformation in colon. J Proteome Res 8(2):702\u2013711","journal-title":"J Proteome Res"},{"issue":"69","key":"40_CR127","doi-asserted-by":"publisher","first-page":"33077","DOI":"10.18632\/oncotarget.26005","volume":"9","author":"R Kawahara","year":"2018","unstructured":"Kawahara R, Ortega F, Rosa-Fernandes L, Guimar\u00e3es V, Quina D, Nahas W et al. (2018) Distinct urinary glycoprotein signatures in prostate cancer patients. Oncotarget 9(69):33077\u201333097","journal-title":"Oncotarget"},{"key":"40_CR128","doi-asserted-by":"publisher","first-page":"100026","DOI":"10.1074\/mcp.RA120.002320","volume":"20","author":"R Kawahara","year":"2021","unstructured":"Kawahara R, Recuero S, Srougi M, Leite KRM, Thaysen-Andersen M, Palmisano G (2021) The complexity and dynamics of the tissue glycoproteome associated with prostate cancer progression. Mol Cell Proteom 20:100026","journal-title":"Mol Cell Proteom"},{"issue":"1","key":"40_CR129","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1021\/acs.analchem.9b02228","volume":"92","author":"X Zhao","year":"2020","unstructured":"Zhao X, Zheng S, Li Y, Huang J, Zhang W, Xie Y et al. (2020) An integrated mass spectrometry data processing strategy for fast identification, in-depth, and reproducible quantification of protein O-glycosylation in a large cohort of human urine samples. Anal Chem 92(1):690\u2013698","journal-title":"Anal Chem"},{"issue":"6","key":"40_CR130","doi-asserted-by":"publisher","first-page":"e2100095","DOI":"10.1002\/prca.202100095","volume":"16","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Xu H, Tian Z (2022) Exploration of quantitative site-specific serum O-glycoproteomics with isobaric labeling for the discovery of putative O-glycoprotein biomarkers. Proteom Clin Appl 16(6):e2100095","journal-title":"Proteom Clin Appl"},{"key":"40_CR131","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jprot.2016.04.009","volume":"145","author":"R Sheta","year":"2016","unstructured":"Sheta R, Woo CM, Roux-Dalvai F, Fournier F, Bourassa S, Droit A et al. (2016) A metabolic labeling approach for glycoproteomic analysis reveals altered glycoprotein expression upon GALNT3 knockdown in ovarian cancer cells. J Proteomics 145:91\u2013102","journal-title":"J Proteomics"},{"key":"40_CR132","doi-asserted-by":"publisher","first-page":"217262","DOI":"10.1016\/j.canlet.2024.217262","volume":"605","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Zhang D, Meng B, Zhang Y, Ma S, Zeng J, Wang X et al. (2024) Integrated proteomic and glycoproteomic analysis reveals heterogeneity and molecular signatures of brain metastases from lung adenocarcinomas. Cancer Lett 605:217262","journal-title":"Cancer Lett"},{"key":"40_CR133","doi-asserted-by":"crossref","unstructured":"Xie C, Schaefer L, Iozzo RV (2023) Global impact of proteoglycan science on human diseases. iScience 26(11):108095","DOI":"10.1016\/j.isci.2023.108095"},{"issue":"15","key":"40_CR134","doi-asserted-by":"publisher","first-page":"3331","DOI":"10.1111\/febs.17107","volume":"291","author":"S Ricard-Blum","year":"2024","unstructured":"Ricard-Blum S, Viv\u00e8s RR, Schaefer L, G\u00f6tte M, Merline R, Passi A et al. (2024) A biological guide to glycosaminoglycans: current perspectives and pending questions. FEBS J 291(15):3331\u20133366","journal-title":"FEBS J"},{"key":"40_CR135","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.matbio.2015.02.003","volume":"42","author":"RV Iozzo","year":"2015","unstructured":"Iozzo RV, Schaefer L (2015) Proteoglycan form and function: a comprehensive nomenclature of proteoglycans. Matrix Biol 42:11\u201355","journal-title":"Matrix Biol"},{"issue":"4","key":"40_CR136","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41568-020-00329-7","volume":"21","author":"TR Cox","year":"2021","unstructured":"Cox TR (2021) The matrix in cancer. Nat Rev Cancer 21(4):217\u2013238","journal-title":"Nat Rev Cancer"},{"key":"40_CR137","doi-asserted-by":"publisher","first-page":"102332","DOI":"10.1016\/j.sbi.2022.102332","volume":"73","author":"MM Kogut","year":"2022","unstructured":"Kogut MM, Marcisz M, Samsonov SA (2022) Modeling glycosaminoglycan\u2013protein complexes. Curr Opin Struct Biol 73:102332","journal-title":"Curr Opin Struct Biol"},{"key":"40_CR138","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s00726-010-0682-4","volume":"41","author":"E Sisu","year":"2011","unstructured":"Sisu E, Flangea C, Serb A, Zamfir AD (2011) Modern developments in mass spectrometry of chondroitin and dermatan sulfate glycosaminoglycans. Amino Acids 41:235\u2013256","journal-title":"Amino Acids"},{"key":"40_CR139","doi-asserted-by":"publisher","first-page":"403","DOI":"10.3390\/cells14060403","volume":"14","author":"E Turlej","year":"2025","unstructured":"Turlej E, Domaradzka A, Radzka J, Drulis-Fajdasz D, Gizak A (2025) Cross-talk between cancer and its cellular microenvironment\u2014a role in cancer. Cells 14:403","journal-title":"Cells"},{"key":"40_CR140","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/978-1-0716-2493-7_11","volume":"2531","author":"AD Zamfir","year":"2022","unstructured":"Zamfir AD (2022) Capillary zone electrophoresis-electrospray ionization tandem mass spectrometry for total analysis of chondroitin\/dermatan sulfate oligosaccharides. Methods Mol Biol 2531:163\u2013184","journal-title":"Methods Mol Biol"},{"issue":"1","key":"40_CR141","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3390\/md22010009","volume":"22","author":"Y Yao","year":"2023","unstructured":"Yao Y, Tang H, Ma H, Liu Z, Huang J, Yang X et al. (2023) Chondroitin sulfate\/dermatan sulfate hybrid chains from swim bladder: isolation, structural analysis, and anticoagulant activity. Marine Drugs 22(1):9","journal-title":"Marine Drugs"},{"issue":"8","key":"40_CR142","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1093\/glycob\/cwac030","volume":"32","author":"O Habuchi","year":"2022","unstructured":"Habuchi O (2022) Functions of chondroitin\/dermatan sulfate containing GalNAc4,6-disulfate. Glycobiology 32(8):664\u2013678","journal-title":"Glycobiology"},{"issue":"10","key":"40_CR143","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1111\/febs.14748","volume":"286","author":"A Pude\u0142ko","year":"2019","unstructured":"Pude\u0142ko A, Wisowski G, Olczyk K, Ko\u017ama EM (2019) The dual role of the glycosaminoglycan chondroitin-6-sulfate in the development, progression and metastasis of cancer. FEBS J 286(10):1815\u20131837","journal-title":"FEBS J"},{"key":"40_CR144","first-page":"114131","volume":"182","author":"AD Theocharis","year":"2022","unstructured":"Theocharis AD, Skandalis SS, Gialeli C, Karamanos NK (2022) Extracellular matrix structure. Adv Drug Deliv Rev 182:114131","journal-title":"Adv Drug Deliv Rev"},{"key":"40_CR145","doi-asserted-by":"publisher","first-page":"654765","DOI":"10.1155\/2015\/654765","volume":"2015","author":"TA J\u00e4rvinen","year":"2015","unstructured":"J\u00e4rvinen TA, Prince S (2015) Decorin: a growth factor antagonist for tumor growth inhibition. BioMed Res Int 2015:654765","journal-title":"BioMed Res Int"},{"key":"40_CR146","doi-asserted-by":"publisher","first-page":"801801","DOI":"10.3389\/fonc.2021.801801","volume":"11","author":"V Diehl","year":"2021","unstructured":"Diehl V, Huber LS, Trebicka J, Wygrecka M, Iozzo RV, Schaefer L (2021) The role of decorin and biglycan signaling in tumorigenesis. Front Oncol 11:801801","journal-title":"Front Oncol"},{"issue":"7","key":"40_CR147","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1158\/1541-7786.MCR-16-0444","volume":"15","author":"Y Mitsui","year":"2017","unstructured":"Mitsui Y, Shiina H, Kato T, Maekawa S, Hashimoto Y, Shiina M et al. (2017) Versican promotes tumor progression, metastasis and predicts poor prognosis in renal carcinoma. Mol Cancer Res 15(7):884\u2013895","journal-title":"Mol Cancer Res"},{"key":"40_CR148","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1369\/0022155420937098","volume":"68","author":"A Papadas","year":"2020","unstructured":"Papadas A, Arauz G, Cicala A, Wiesner J, Asimakopoulos F (2020) Versican and versican-matrikines in cancer progression, inflammation, and immunity. J Histochem Cytochem 68:12","journal-title":"J Histochem Cytochem"},{"issue":"1","key":"40_CR149","doi-asserted-by":"publisher","first-page":"146","DOI":"10.3390\/ijms23010146","volume":"23","author":"S Niland","year":"2021","unstructured":"Niland S, Riscanevo AX, Eble JA (2021) Matrix metalloproteinases shape the tumor microenvironment in cancer progression. Int J Mol Sci 23(1):146","journal-title":"Int J Mol Sci"},{"key":"40_CR150","doi-asserted-by":"publisher","first-page":"914838","DOI":"10.3389\/fonc.2022.914838","volume":"12","author":"S Nadanaka","year":"2022","unstructured":"Nadanaka S, Tamura J-I, Kitagawa H (2022) Chondroitin sulfates control invasiveness of basal-like breast cancer cells cell line MDA-MB-231 through ROR1. Front Oncol 12:914838","journal-title":"Front Oncol"},{"key":"40_CR151","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41392-021-00762-6","volume":"7","author":"J Liu","year":"2022","unstructured":"Liu J, Xiao Q, Xiao J, Niu C, Li Y, Zhang X et al. (2022) Wnt\/\u03b2-catenin signaling: Function, biological mechanisms and therapeutic opportunities. Signal Transduct Target Ther 7:3","journal-title":"Signal Transduct Target Ther"},{"key":"40_CR152","doi-asserted-by":"publisher","first-page":"3435","DOI":"10.1002\/pmic.200800440","volume":"9","author":"AD Zamfir","year":"2009","unstructured":"Zamfir AD, Flangea C, Serb A, Sisu E, Dinca N, Bruckner P et al. (2009) Analysis of novel over- and undersulfated glycosaminoglycan sequences by enzyme cleavage and multiple stage mass spectrometry. Proteomics 9:3435\u20133444","journal-title":"Proteomics"},{"issue":"45","key":"40_CR153","doi-asserted-by":"publisher","first-page":"17969","DOI":"10.1021\/acs.analchem.4c02706","volume":"96","author":"A Devlin","year":"2024","unstructured":"Devlin A, Green F, Takats Z (2024) Mass spectrometry imaging with trapped ion mobility spectrometry enables spatially resolved chondroitin, dermatan, and hyaluronan glycosaminoglycan oligosaccharide analysis in situ. Anal Chem 96(45):17969\u201317977","journal-title":"Anal Chem"},{"issue":"8","key":"40_CR154","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1158\/0008-5472.CAN-11-1351","volume":"72","author":"MA Thelin","year":"2012","unstructured":"Thelin MA, Svensson KJ, Shi X, Bagher M, Axelsson J, Isinger-Ekstrand A et al. (2012) Dermatan sulfate is involved in the tumorigenic properties of esophagus squamous cell carcinoma. Cancer Res 72(8):1943\u20131952","journal-title":"Cancer Res"},{"issue":"4","key":"40_CR155","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1590\/S1679-45082015AO3477","volume":"13","author":"APC Marolla","year":"2015","unstructured":"Marolla APC, Waisberg J, Saba GT, Waisberg DR, Margeotto FB, Pinhal M (2015) Glycomics expression analysis of sulfated glycosaminoglycans of human colorectal cancer tissues and non-neoplastic mucosa by electrospray ionization mass spectrometry. Einstein (S\u00e3o Paulo) 13(4):510\u2013517","journal-title":"Einstein (S\u00e3o Paulo)"},{"key":"40_CR156","doi-asserted-by":"publisher","first-page":"100025","DOI":"10.1074\/mcp.R120.002267","volume":"20","author":"LE Pepi","year":"2021","unstructured":"Pepi LE, Sanderson P, Stickney M, Amster IJ (2021) Developments in mass spectrometry for glycosaminoglycan analysis: a review. Mol Cell Proteomics 20:100025","journal-title":"Mol Cell Proteomics"},{"issue":"10","key":"40_CR157","doi-asserted-by":"publisher","first-page":"5166","DOI":"10.1021\/acs.analchem.6b00155","volume":"88","author":"M Sarbu","year":"2016","unstructured":"Sarbu M, Robu AC, Ghiulai RM, Vukeli\u0107 \u017d, Clemmer DE, Zamfir AD (2016) Electrospray ionization ion mobility mass spectrometry of human brain gangliosides. Anal Chem 88(10):5166\u20135178","journal-title":"Anal Chem"},{"key":"40_CR158","doi-asserted-by":"publisher","first-page":"e4908","DOI":"10.1002\/jms.4908","volume":"58","author":"M Sarbu","year":"2023","unstructured":"Sarbu M, Ica R, Sharon E, Clemmer DE, Zamfir AD (2023) Glycomics by ion mobility tandem mass spectrometry of chondroitin sulfate disaccharide domain in biglycan. J Mass Spectromet 58:e4908","journal-title":"J Mass Spectromet"},{"issue":"12","key":"40_CR159","doi-asserted-by":"publisher","first-page":"10296","DOI":"10.3390\/ijms241210296","volume":"24","author":"GN Iaconisi","year":"2023","unstructured":"Iaconisi GN, Lunetti P, Gallo N, Cappello AR, Fiermonte G, Dolce V et al. (2023) Hyaluronic acid: a powerful biomolecule with wide-ranging applications-a comprehensive review. Int J Mol Sci 24(12):10296","journal-title":"Int J Mol Sci"},{"issue":"14","key":"40_CR160","doi-asserted-by":"publisher","first-page":"e2203143","DOI":"10.1002\/adhm.202203143","volume":"12","author":"G Safarians","year":"2023","unstructured":"Safarians G, Sohrabi A, Solomon I, Xiao W, Bastola S, Rajput BW et al. (2023) Glioblastoma spheroid invasion through soft, brain-like matrices depends on hyaluronic acid \u2013CD44 interactions. Adv Healthc Mater 12(14):e2203143","journal-title":"Adv Healthc Mater"},{"issue":"12","key":"40_CR161","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.3390\/biom11121850","volume":"11","author":"M Hassn Mesrati","year":"2021","unstructured":"Hassn Mesrati M, Syafruddin SE, Mohtar MA, Syahir A (2021) CD44: a multifunctional mediator of cancer progression. Biomolecules 11(12):1850","journal-title":"Biomolecules"},{"key":"40_CR162","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3389\/fmolb.2019.00160","volume":"6","author":"E Henke","year":"2020","unstructured":"Henke E, Nandigama R, Erg\u00fcn S (2020) Extracellular matrix in the tumor microenvironment and its impact on cancer therapy. Front Mol Biosci 6:160","journal-title":"Front Mol Biosci"},{"key":"40_CR163","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/S1357-2725(02)00264-9","volume":"35","author":"AD Theocharis","year":"2003","unstructured":"Theocharis AD, Vynios DH, Papageorgakopoulou N, Skandalis SS, Theocharis DA (2003) Altered content composition and structure of glycosaminoglycans and proteoglycans in gastric carcinoma. Int J Biochem Cell Biol 35:376\u2013390","journal-title":"Int J Biochem Cell Biol"},{"issue":"11","key":"40_CR164","doi-asserted-by":"publisher","first-page":"e80765","DOI":"10.1371\/journal.pone.0080765","volume":"8","author":"XB Cheng","year":"2013","unstructured":"Cheng XB, Sato N, Kohi S, Yamaguchi K (2013) Prognostic impact of hyaluronan and its regulators in pancreatic ductal adenocarcinoma. PLoS ONE 8(11):e80765","journal-title":"PLoS ONE"},{"key":"40_CR165","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1002\/(SICI)1097-0215(19971021)74:5<477::AID-IJC1>3.0.CO;2-0","volume":"74","author":"PK Auvinen","year":"1997","unstructured":"Auvinen PK, Parkkinen JJ, Johansson RT, Agren UM, Tammi RH, Eskelinen MJ et al. (1997) Expression of hyaluronan in benign and malignant breast lesions. Int J Cancer 74:477\u2013481","journal-title":"Int J Cancer"},{"issue":"2","key":"40_CR166","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/bjc.2017.327","volume":"118","author":"JR Infante","year":"2018","unstructured":"Infante JR, Korn RL, Rosen LS, LoRusso P, Dychter SS, Zhu J et al. (2018) Phase 1 trials of PEGylated recombinant human hyaluronidase PH20 in patients with advanced solid tumours. Brit J Cancer 118(2):153\u2013161","journal-title":"Brit J Cancer"},{"issue":"3","key":"40_CR167","doi-asserted-by":"publisher","first-page":"426","DOI":"10.34172\/apb.2021.050","volume":"11","author":"GE Chaudhry","year":"2021","unstructured":"Chaudhry GE, Akim A, Naveed Zafar M, Safdar N, Sung YY, Muhammad TST (2021) Understanding hyaluronan receptor (CD44) interaction, HA\u2013CD44 activated potential targets in cancer therapeutics.. Adv Pharmaceut Bull 11(3):426\u2013438","journal-title":"Adv Pharmaceut Bull"},{"key":"40_CR168","doi-asserted-by":"publisher","first-page":"800481","DOI":"10.3389\/fphar.2021.800481","volume":"12","author":"P Kesharwani","year":"2022","unstructured":"Kesharwani P, Chadar R, Sheikh A, Rizg WY, Safhi AY (2022) CD44-targeted nanocarrier for cancer therapy. Front Pharmacol 12:800481","journal-title":"Front Pharmacol"},{"key":"40_CR169","doi-asserted-by":"publisher","first-page":"142486","DOI":"10.1016\/j.ijbiomac.2025.142486","volume":"308","author":"AR Al Jayoush","year":"2025","unstructured":"Al Jayoush AR, Haider M, Ahmad Khan S, Hussain Z (2025) Hyaluronic acid-functionalized nanomedicines for CD44-receptor\u2013mediated targeted cancer therapy: a review of selective targetability and biodistribution to tumor microenvironment. Int J Biol Macromol 308:142486","journal-title":"Int J Biol Macromol"},{"key":"40_CR170","doi-asserted-by":"publisher","first-page":"117014","DOI":"10.1016\/j.carbpol.2020.117014","volume":"250","author":"M \u0160imek","year":"2020","unstructured":"\u0160imek M, Lemr K, Hermannov\u00e1 M, Havl\u00ed\u010dek V (2020) Analysis of hyaluronan and its derivatives using chromatographic and mass spectrometric techniques. Carbohydrate Polymers 250:117014","journal-title":"Carbohydrate Polymers"},{"issue":"19","key":"40_CR171","doi-asserted-by":"publisher","first-page":"5781","DOI":"10.1007\/s00216-022-04139-8","volume":"414","author":"R Legouffe","year":"2022","unstructured":"Legouffe R, Jeanneton O, Gaudin M, Tomezyk A, Gerstenberg A, Dumas M et al. (2022) Hyaluronic acid detection and relative quantification by mass spectrometry imaging in human skin tissues. Anal Bioanal Chem 414(19):5781\u20135791","journal-title":"Anal Bioanal Chem"},{"key":"40_CR172","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.colsurfb.2011.10.029","volume":"99","author":"KY Choi","year":"2012","unstructured":"Choi KY, Saravanakumar G, Park JH, Park K (2012) Hyaluronic acid-based nanocarriers for intracellular targeting: interfacial interactions with proteins in cancer. Colloids Surf B Biointerf 99:82\u201394","journal-title":"Colloids Surf B Biointerf"},{"key":"40_CR173","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1038\/bjc.2017.318","volume":"117","author":"DS Morera","year":"2017","unstructured":"Morera DS, Hennig MS, Talukder A, Lokeshwar SD, Wang J, Garcia-Roig M et al. (2017) Hyaluronic acid family in bladder cancer: potential prognostic biomarkers and therapeutic targets. Brit J Cancer 117:1507\u20131517","journal-title":"Brit J Cancer"},{"issue":"4","key":"40_CR174","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1093\/glycob\/cwy003","volume":"28","author":"B Caterson","year":"2018","unstructured":"Caterson B, Melrose J (2018) Keratan sulfate: a complex glycosaminoglycan with unique functional capability. Glycobiology 28(4):182\u2013206","journal-title":"Glycobiology"},{"issue":"2","key":"40_CR175","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1021\/acsabm.1c01240","volume":"5","author":"B Boyraz","year":"2022","unstructured":"Boyraz B, Saatz J, Pomp\u00f6s IM, Gad M, Dernedde J, Maier AB et al. (2022) Imaging keratan sulfate in ocular tissue sections by immunofluorescence microscopy and LA-ICP-MS. ACS Appl Bio Mater 5(2):853\u2013861","journal-title":"ACS Appl Bio Mater"},{"key":"40_CR176","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/978-3-031-12390-0_5","volume":"29","author":"NB Schwartz","year":"2023","unstructured":"Schwartz NB, Domowicz MS (2023) Chemistry and function of glycosaminoglycans in the nervous system. Adv Neurobiol 29:117\u2013162","journal-title":"Adv Neurobiol"},{"issue":"10","key":"40_CR177","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1111\/1346-8138.16506","volume":"49","author":"K Tachibana","year":"2022","unstructured":"Tachibana K, Ohkawa Y, Kanto N, Maeda K, Ohe S, Isei T et al. (2022) The expression of keratan sulfate in malignant melanoma enhances the adhesion and invasion activity of melanoma cells. J Dermatol 49(10):1027\u20131036","journal-title":"J Dermatol"},{"issue":"16","key":"40_CR178","doi-asserted-by":"publisher","first-page":"9490","DOI":"10.1074\/jbc.271.16.9490","volume":"271","author":"K Takahashi","year":"1996","unstructured":"Takahashi K, Stamenkovic I, Cutler M, Dasgupta A, Tanabe KK (1996) Keratan sulfate modification of CD44 modulates adhesion to hyaluronate. J Biol Chem 271(16):9490\u20139496","journal-title":"J Biol Chem"},{"issue":"1","key":"40_CR179","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-46046-6","volume":"9","author":"PD Leiphrakpam","year":"2019","unstructured":"Leiphrakpam PD, Patil PP, Remmers N, Swanson B, Grandgenett PM, Qiu F et al. (2019) Role of keratan sulfate expression in human pancreatic cancer malignancy. Sci Rep 9(1):9665","journal-title":"Sci Rep"},{"issue":"4","key":"40_CR180","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.bbrc.2008.02.130","volume":"369","author":"Y Kato","year":"2008","unstructured":"Kato Y, Hayatsu N, Kaneko MK, Ogasawara S, Hamano T, Takahashi S et al. (2008) Increased expression of highly sulfated keratan sulfate synthesized in malignant astrocytic tumors. Biochem Biophys Res Commun 369(4):1041\u20131046","journal-title":"Biochem Biophys Res Commun"},{"key":"40_CR181","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ab.2014.08.005","volume":"467","author":"H Osago","year":"2014","unstructured":"Osago H, Shibata T, Hara N, Kuwata S, Kono M, Uchio Y et al. (2014) Quantitative analysis of glycosaminoglycans, chondroitin\/dermatan sulfate, hyaluronic acid, heparan sulfate, and keratan sulfate by liquid chromatography\u2013electrospray ionization\u2013tandem mass spectrometry. Anal Biochem 467:62\u201374","journal-title":"Anal Biochem"},{"key":"40_CR182","doi-asserted-by":"publisher","first-page":"114339","DOI":"10.1016\/j.jpba.2021.114339","volume":"205","author":"Q Ren","year":"2021","unstructured":"Ren Q, Wang J, Liu C, Meng L, Qian R, Gao H et al. (2021) Exploring the sulfate patterns of chondroitin sulfate\/dermatan sulfate and keratan sulfate in human pancreatic cancer. J Pharmaceut Biomed Anal 205:114339","journal-title":"J Pharmaceut Biomed Anal"},{"issue":"3","key":"40_CR183","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1021\/ac040074j","volume":"77","author":"Y Zhang","year":"2005","unstructured":"Zhang Y, Kariya Y, Conrad AH, Tasheva ES, Conrad GW (2005) Analysis of keratan sulfate oligosaccharides by electrospray ionization tandem mass spectrometry. Anal Chem 77(3):902\u2013910","journal-title":"Anal Chem"},{"key":"40_CR184","doi-asserted-by":"crossref","unstructured":"Ellsworth KA, Pollard LM, Cathey S, Wood T (2016) Measurement of elevated concentrations of urine keratan sulfate by UPLC-MSMS in lysosomal storage disorders (LSDs): comparison of urine keratan sulfate levels in MPS IVA versus other LSDs. In: Morava E, Baumgartner M, Patterson M, Rahman S, Zschocke J, Peters V (eds), JIMD Reports, vol 34. Springer.","DOI":"10.1007\/8904_2016_1"},{"key":"40_CR185","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/bs.ircmb.2016.02.009","volume":"325","author":"JP Li","year":"2016","unstructured":"Li JP, Kusche-Gullberg M (2016) Heparan sulfate: biosynthesis, structure, and function. Int Rev Cell Mol Biol 325:215\u2013273","journal-title":"Int Rev Cell Mol Biol"},{"issue":"6","key":"40_CR186","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/S1367-5931(00)00145-9","volume":"4","author":"R Sasisekharan","year":"2000","unstructured":"Sasisekharan R, Venkataraman G (2000) Heparin and heparan sulfate: biosynthesis, structure and function. Curr Opin Chem Biol 4(6):626\u2013631","journal-title":"Curr Opin Chem Biol"},{"key":"40_CR187","doi-asserted-by":"crossref","unstructured":"Kjell\u00e9n L, Lindahl U (2024) Heparin and heparan sulfate\u2014the essence of sequence. Proteoglycan Res 2:e70006","DOI":"10.1002\/pgr2.70006"},{"issue":"7\u20138","key":"40_CR188","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1007\/s00018-007-7455-6","volume":"65","author":"SO Kolset","year":"2008","unstructured":"Kolset SO, Tveit H (2008) Serglycin: structure and biology. Cell Mol Life Sci 65(7\u20138):1073\u20131085","journal-title":"Cell Mol Life Sci"},{"issue":"12","key":"40_CR189","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.1111\/jth.15052","volume":"18","author":"AR Rezaie","year":"2020","unstructured":"Rezaie AR, Giri H (2020) Anticoagulant and signaling functions of antithrombin. J Thromb Haemost 18(12):3142\u20133153","journal-title":"J Thromb Haemost"},{"issue":"3","key":"40_CR190","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3390\/medicines6030080","volume":"6","author":"G Ghiselli","year":"2019","unstructured":"Ghiselli G (2019) Heparin binding proteins as therapeutic target: an historical account and current trends. Medicines 6(3):80","journal-title":"Medicines"},{"key":"40_CR191","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1146\/annurev.biochem.71.110601.135458","volume":"71","author":"JD Esko","year":"2002","unstructured":"Esko JD, Selleck SB (2002) Order out of chaos: assembly of ligand binding sites in heparan sulfate. Ann Rev Biochem 71:435\u2013471","journal-title":"Ann Rev Biochem"},{"issue":"7","key":"40_CR192","first-page":"a004952","volume":"3","author":"S Sarrazin","year":"2011","unstructured":"Sarrazin S, Lamanna WC, Esko JD (2011) Heparan sulfate proteoglycans. Cold Spring Harbor Perspectives in. Biology 3(7):a004952","journal-title":"Biology"},{"key":"40_CR193","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3389\/fendo.2018.00483","volume":"9","author":"A Nagarajan","year":"2018","unstructured":"Nagarajan A, Malvi P, Wajapeyee N (2018) Heparan sulfate and heparan sulfate proteoglycans in cancer initiation and progression. Front Endocrinol 9:483","journal-title":"Front Endocrinol"},{"key":"40_CR194","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/978-3-030-40146-7_7","volume":"1245","author":"B Bartolini","year":"2020","unstructured":"Bartolini B, Carav\u00e0 E, Caon I, Parnigoni A, Moretto P, Passi A et al. (2020) Heparan sulfate in the tumor microenvironment. Adv Exp Med Biol 1245:147\u2013161","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"40_CR195","doi-asserted-by":"publisher","first-page":"136","DOI":"10.3390\/biom11020136","volume":"11","author":"I Faria-Ramos","year":"2021","unstructured":"Faria-Ramos I, Po\u00e7as J, Marques C, Santos-Antunes J, Macedo G, Reis CA et al. (2021) Heparan sulfate glycosaminoglycans: (un)expected allies in cancer clinical management. Biomolecules 11(2):136","journal-title":"Biomolecules"},{"issue":"6","key":"40_CR196","doi-asserted-by":"publisher","first-page":"541","DOI":"10.2174\/1389557516666161101143643","volume":"17","author":"H Jin","year":"2017","unstructured":"Jin H, Zhou S (2017) The functions of heparanase in human diseases. Mini-Rev Med Chem 17(6):541\u2013548","journal-title":"Mini-Rev Med Chem"},{"issue":"12","key":"40_CR197","doi-asserted-by":"publisher","first-page":"4277","DOI":"10.31557\/APJCP.2023.24.12.4277","volume":"24","author":"SI Amer Ismail","year":"2023","unstructured":"Amer Ismail SI, Helmy ET, Abdel Aziz AM, Shibel PEE (2023) Immunohistochemical evaluation of perlecan (heparan sulphate proteoglycan 2) expression in invasive female breast carcinoma. Asian Pacific J Cancer Prevent 24(12):4277\u20134283","journal-title":"Asian Pacific J Cancer Prevent"},{"issue":"19","key":"40_CR198","doi-asserted-by":"publisher","first-page":"6344","DOI":"10.1074\/jbc.RA120.012525","volume":"295","author":"A Kapoor","year":"2020","unstructured":"Kapoor A, Chen CG, Iozzo RV (2020) Endorepellin evokes an angiostatic stress signaling cascade in endothelial cells. J Biol Chem 295(19):6344\u20136356","journal-title":"J Biol Chem"},{"issue":"19","key":"40_CR199","doi-asserted-by":"publisher","first-page":"3462","DOI":"10.1242\/jcs.034827","volume":"122","author":"AM Avalos","year":"2009","unstructured":"Avalos AM, Valdivia AD, Mu\u00f1oz N, Herrera-Molina R, Tapia JC, Lavandero S et al. (2009) Neuronal Thy-1 induces astrocyte adhesion by engaging syndecan-4 in a cooperative interaction with \u03b1v\u03b23 integrin that activates PKC\u03b1 and RhoA. J Cell Sci 122(19):3462\u20133471","journal-title":"J Cell Sci"},{"issue":"30","key":"40_CR200","doi-asserted-by":"publisher","first-page":"15116","DOI":"10.1073\/pnas.1902041116","volume":"116","author":"AT Timberlake","year":"2019","unstructured":"Timberlake AT, Jin SC, Nelson-Williams C, Wu R, Furey CG, Islam B et al. (2019) Mutations in TFAP2B and previously unimplicated genes of the BMP, Wnt, and Hedgehog pathways in syndromic craniosynostosis. Proc Natl Acad Sci 116(30):15116\u201315121","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"40_CR201","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1080\/19336918.2020.1767489","volume":"14","author":"SN Ma","year":"2020","unstructured":"Ma SN, Mao ZX, Wu Y, Liang MX, Wang DD, Chen X et al. (2020) The anti-cancer properties of heparin and its derivatives: a review and prospect. Cell Adhes Migr 14(1):118\u2013128","journal-title":"Cell Adhes Migr"},{"issue":"4","key":"40_CR202","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3390\/ph10040078","volume":"10","author":"S Mohamed","year":"2017","unstructured":"Mohamed S, Coombe DR (2017) Heparin mimetics: their therapeutic potential. Pharmaceuticals 10(4):78","journal-title":"Pharmaceuticals"},{"key":"40_CR203","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.drup.2016.10.001","volume":"29","author":"I Vlodavsky","year":"2016","unstructured":"Vlodavsky I, Singh P, Boyango I, Gutter-Kapon L, Elkin M, Sanderson RD et al. (2016) Heparanase: From basic research to therapeutic applications in cancer and inflammation. Drug Resist Updat 29:54\u201375","journal-title":"Drug Resist Updat"},{"key":"40_CR204","first-page":"360","volume":"15","author":"CD Mohan","year":"2019","unstructured":"Mohan CD, Hari S, Preetham HD, Rangappa S, Barash U, Ilan N et al. (2019) Targeting heparanase in cancer: inhibition by synthetic, chemically modified, and natural compounds. iScience 15:360\u2013390","journal-title":"Targeting heparanase in cancer: inhibition by synthetic, chemically modified, and natural compounds. iScience"},{"issue":"11","key":"40_CR205","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.3390\/molecules23112915","volume":"23","author":"C Lanzi","year":"2018","unstructured":"Lanzi C, Cassinelli G (2018) Heparan sulfate mimetics in cancer therapy: the challenge to define structural determinants and the relevance of targets for optimal activity. Molecules 23(11):2915","journal-title":"Molecules"},{"issue":"13","key":"40_CR206","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.1021\/ac0340455","volume":"75","author":"OM Saad","year":"2003","unstructured":"Saad OM, Leary JA (2003) Compositional analysis and quantification of heparin and heparan sulfate by electrospray ionization ion trap mass spectrometry. Anal Chem 75(13):2985\u20132995","journal-title":"Anal Chem"},{"issue":"4","key":"40_CR207","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.3390\/metabo2041060","volume":"2","author":"TM Puvirajesinghe","year":"2012","unstructured":"Puvirajesinghe TM, Turnbull JE (2012) Glycomics approaches for the bioassay and structural analysis of heparin\/heparan sulphates. Metabolites 2(4):1060\u20131089","journal-title":"Metabolites"},{"key":"40_CR208","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.chroma.2018.02.052","volume":"1545","author":"P Sanderson","year":"2018","unstructured":"Sanderson P, Stickney M, Leach IIIFE, Xia Q, Yu Y, Zhang F et al. (2018) Heparin\/heparan sulfate analysis by covalently modified reverse polarity capillary zone electrophoresis\u2013mass spectrometry. J Chromatogr A 1545:75\u201383","journal-title":"J Chromatogr A"},{"key":"40_CR209","doi-asserted-by":"publisher","first-page":"121270","DOI":"10.1016\/j.talanta.2020.121270","volume":"219","author":"M Qiao","year":"2020","unstructured":"Qiao M, Lin L, Xia K, Li J, Zhang X, Linhardt RJ (2020) Recent advances in biotechnology for heparin and heparan sulfate analysis. Talanta 219:121270","journal-title":"Talanta"},{"key":"40_CR210","doi-asserted-by":"publisher","first-page":"462049","DOI":"10.1016\/j.chroma.2021.462049","volume":"1643","author":"L Chen","year":"2021","unstructured":"Chen L, Ouyang Y, Yan N, Guo Y, Yi L, Sun Y et al. (2021) Comprehensive analysis of heparinase-derived heparin products using two-dimensional liquid chromatography coupled with mass spectrometry. J Chromatogr A 1643:462049","journal-title":"J Chromatogr A"},{"issue":"4","key":"40_CR211","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1074\/mcp.M112.026880","volume":"12","author":"MJ Kailemia","year":"2013","unstructured":"Kailemia MJ, Li L, Xu Y, Liu J, Linhardt RJ, Amster IJ (2013) Structurally informative tandem mass spectrometry of highly sulfated natural and chemoenzymatically synthesized heparin and heparan sulfate glycosaminoglycans. Mol Cell Proteomics 12(4):979\u2013990","journal-title":"Mol Cell Proteomics"},{"issue":"12","key":"40_CR212","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1158\/1541-7786.MCR-17-0352","volume":"15","author":"VM Tran","year":"2017","unstructured":"Tran VM, Wade A, McKinney A, Chen K, Lindberg OR, Engler JR et al. (2017) Heparan sulfate glycosaminoglycans in glioblastoma promote tumor invasion. Mo Cancer Res 15(12):1623\u20131633","journal-title":"Mo Cancer Res"},{"issue":"49","key":"40_CR213","doi-asserted-by":"publisher","first-page":"34141","DOI":"10.1074\/jbc.M114.589630","volume":"289","author":"Y Mao","year":"2014","unstructured":"Mao Y, Huang Y, Buczek-Thomas JA, Ethen CM, Nugent MA, Wu ZL et al. (2014) A liquid chromatography\u2013mass spectrometry-based approach to characterize the substrate specificity of mammalian heparanase. J Biol Chem 289(49):34141\u201334151","journal-title":"J Biol Chem"},{"issue":"13","key":"40_CR214","doi-asserted-by":"publisher","first-page":"7050","DOI":"10.3390\/ijms24087050","volume":"24","author":"D P\u00e1l","year":"2023","unstructured":"P\u00e1l D, T\u00f3th G, Sug\u00e1r S, F\u00fcgedi KD, Szab\u00f3 D, Kovalszky I et al. (2023) Compositional analysis of glycosaminoglycans in different lung cancer types: a pilot study. Int J Mol Sci 24(13):7050","journal-title":"Int J Mol Sci"},{"key":"40_CR215","doi-asserted-by":"publisher","first-page":"108556","DOI":"10.1016\/j.carres.2022.108556","volume":"516","author":"RCR Jala","year":"2022","unstructured":"Jala RCR, Vudhgiri S, Kumar CG (2022) A comprehensive review on natural occurrence, synthesis and biological activities of glycolipids. Carbohydr Res 516:108556","journal-title":"Carbohydr Res"},{"issue":"13\u201316","key":"40_CR216","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1080\/10826076.2023.2165097","volume":"45","author":"AB Daku","year":"2022","unstructured":"Daku AB, Al-Mhanna SB, Abu Bakar R, Nurul AA (2022) Glycolipids isolation and characterization from natural sources: A review. J Liquid Chromatogr Relat Technol 45(13\u201316):165\u2013173","journal-title":"J Liquid Chromatogr Relat Technol"},{"key":"40_CR217","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.carres.2014.10.005","volume":"402","author":"CI Crucho","year":"2015","unstructured":"Crucho CI, Correia-da-Silva P, Petrova KT, Barros MT (2015) Recent progress in the field of glycoconjugates. Carbohydr Res 402:124\u2013132","journal-title":"Carbohydr Res"},{"issue":"9","key":"40_CR218","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1002\/2211-5463.13651","volume":"13","author":"F Spanos","year":"2023","unstructured":"Spanos F, Deleidi M (2023) Glycolipids in Parkinson\u2019s disease: beyond neuronal function. FEBS Open Bio 13(9):1558\u20131579","journal-title":"FEBS Open Bio"},{"issue":"2","key":"40_CR219","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s10719-022-10052-0","volume":"39","author":"X He","year":"2022","unstructured":"He X, Guan F, Lei L (2022) Structure and function of glycosphingolipids on small extracellular vesicles. Glycoconj J 39(2):197\u2013205","journal-title":"Glycoconj J"},{"key":"40_CR220","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/bs.acr.2014.11.004","volume":"126","author":"S Holst","year":"2015","unstructured":"Holst S, Wuhrer M, Rombouts Y (2015) Glycosylation characteristics of colorectal cancer. Adv Cancer Res 126:203\u2013256","journal-title":"Adv Cancer Res"},{"issue":"9","key":"40_CR221","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1007\/s11064-010-0358-1","volume":"36","author":"M Yanagisawa","year":"2011","unstructured":"Yanagisawa M (2011) Stem cell glycolipids. Neurochem Res 36(9):1623\u20131635","journal-title":"Neurochem Res"},{"key":"40_CR222","doi-asserted-by":"publisher","first-page":"300","DOI":"10.3389\/fonc.2015.00300","volume":"5","author":"JL Daniotti","year":"2016","unstructured":"Daniotti JL, Lardone RD, Vilcaes AA (2016) Dysregulated expression of glycolipids in tumor cells: From negative modulator of anti-tumor immunity to promising targets for developing therapeutic agents. Front Oncol 5:300","journal-title":"Front Oncol"},{"key":"40_CR223","doi-asserted-by":"publisher","first-page":"306","DOI":"10.3389\/fonc.2013.00306","volume":"3","author":"JL Daniotti","year":"2013","unstructured":"Daniotti JL, Vilcaes AA, Torres Demichelis V, Ruggiero FM, Rodriguez-Walker M (2013) Glycosylation of glycolipids in cancer: Basis for development of novel therapeutic approaches. Front Oncol 3:306","journal-title":"Front Oncol"},{"issue":"7","key":"40_CR224","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.3390\/biomedicines10071518","volume":"10","author":"B Puljko","year":"2022","unstructured":"Puljko B, Stojanovi\u0107 M, Ilic K, Kalanj-Bognar S, Mlinac-Jerkovic K (2022) Start me up: How can surrounding gangliosides affect sodium-potassium ATPase activity and steer towards pathological ion imbalance in neurons?. Biomedicines 10(7):1518","journal-title":"Biomedicines"},{"issue":"2","key":"40_CR225","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/j.1365-2249.2011.04516.x","volume":"167","author":"LG Durrant","year":"2012","unstructured":"Durrant LG, Noble P, Spendlove I (2012) Immunology in the clinic review series; focus on cancer: Glycolipids as targets for tumour immunotherapy. Clin Experim Immunol 167(2):206\u2013215","journal-title":"Clin Experim Immunol"},{"issue":"20","key":"40_CR226","doi-asserted-by":"publisher","first-page":"15603","DOI":"10.1021\/acs.chemrev.1c01032","volume":"122","author":"SS Shivatare","year":"2022","unstructured":"Shivatare SS, Shivatare VS, Wong CH (2022) Glycoconjugates: synthesis, functional studies, and therapeutic developments. Chem Rev 122(20):15603\u201315671","journal-title":"Chem Rev"},{"key":"40_CR227","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/bs.accb.2018.09.002","volume":"76","author":"RL Schnaar","year":"2019","unstructured":"Schnaar RL (2019) The biology of gangliosides. Adv Carbohydr Chem Biochem 76:113\u2013148","journal-title":"Adv Carbohydr Chem Biochem"},{"key":"40_CR228","doi-asserted-by":"publisher","first-page":"572965","DOI":"10.3389\/fnins.2020.572965","volume":"14","author":"S Sipione","year":"2020","unstructured":"Sipione S, Monyror J, Galleguillos D, Steinberg N, Kadam V (2020) Gangliosides in the brain: physiology, pathophysiology and therapeutic applications. Front Neurosci 14:572965","journal-title":"Front Neurosci"},{"issue":"1\u20133","key":"40_CR229","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/0009-3084(86)90040-X","volume":"42","author":"S Sonnino","year":"1986","unstructured":"Sonnino S, Acquotti D, Riboni L, Giuliani A, Kirschner G, Tettamanti G (1986) New chemical trends in ganglioside research. Chem Phys Lipids 42(1\u20133):3\u201326","journal-title":"Chem Phys Lipids"},{"issue":"4","key":"40_CR230","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/s41423-020-0388-9","volume":"17","author":"G Cutillo","year":"2020","unstructured":"Cutillo G, Saariaho AH, Meri S (2020) Physiology of gangliosides and the role of antiganglioside antibodies in human diseases. Cell Mol Immunol 17(4):313\u2013322","journal-title":"Cell Mol Immunol"},{"issue":"2","key":"40_CR231","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.jpba.2009.04.023","volume":"51","author":"R Lacomba","year":"2010","unstructured":"Lacomba R, Salcedo J, Alegr\u00eda A, Lagarda MJ, Barber\u00e1 R, Matencio E (2010) Determination of sialic acid and gangliosides in biological samples and dairy products: a review. J Pharmaceut Biomed Anal 51(2):346\u2013357","journal-title":"J Pharmaceut Biomed Anal"},{"issue":"2","key":"40_CR232","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.3390\/ijms25021335","volume":"25","author":"MR Biricioiu","year":"2024","unstructured":"Biricioiu MR, Sarbu M, Ica R, Vukeli\u0107 \u017d, Kalanj-Bognar S, Zamfir AD (2024) Advances in mass spectrometry of gangliosides expressed in brain cancers. Int J Mol Sci 25(2):1335","journal-title":"Int J Mol Sci"},{"issue":"1","key":"40_CR233","first-page":"171","volume":"32","author":"B Radi\u0107","year":"2008","unstructured":"Radi\u0107 B, Vukeli\u0107 \u017d, Kalanj-Bognar S (2008) Serum gangliosides in patients with brain tumors. Coll Antropol 32(1):171\u2013175","journal-title":"Coll Antropol"},{"issue":"5","key":"40_CR234","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.sbi.2006.08.006","volume":"16","author":"SM Haslam","year":"2006","unstructured":"Haslam SM, North SJ, Dell A (2006) Mass spectrometric analysis of N- and O-glycosylation of tissues and cells. Curr Opin Struct Biol 16(5):584\u2013591","journal-title":"Curr Opin Struct Biol"},{"issue":"1","key":"40_CR235","doi-asserted-by":"publisher","first-page":"92","DOI":"10.2174\/187152008783330815","volume":"8","author":"L Cipolla","year":"2008","unstructured":"Cipolla L, Peri F, Airoldi C (2008) Glycoconjugates in cancer therapy. Anticancer Agents Med Chem 8(1):92\u2013121","journal-title":"Anticancer Agents Med Chem"},{"issue":"177","key":"40_CR236","doi-asserted-by":"publisher","first-page":"E179","DOI":"10.4052\/tigg.1306.1E","volume":"30","author":"XL Sun","year":"2018","unstructured":"Sun XL (2018) Chemical regulation of glycosylation processes. Trends Glycosci Glycotechnol 30(177):E179\u2013E193","journal-title":"Trends Glycosci Glycotechnol"},{"issue":"2","key":"40_CR237","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s10719-022-10051-1","volume":"39","author":"K Furukawa","year":"2022","unstructured":"Furukawa K, Ohmi Y, Hamamura K, Kondo Y, Ohkawa Y, Kaneko K et al. (2022) Signaling domains of cancer-associated glycolipids. Glycoconj J 39(2):145\u2013155","journal-title":"Glycoconj J"},{"issue":"5","key":"40_CR238","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1021\/jasms.1c00088","volume":"32","author":"M Sarbu","year":"2021","unstructured":"Sarbu M, Petrica L, Clemmer DE, Vukeli\u0107 \u017d, Zamfir AD (2021) Gangliosides of human glioblastoma multiforme: a comprehensive mapping and structural analysis by ion mobility tandem mass spectrometry. J Am So Mass Spectrom 32(5):1249\u20131257","journal-title":"J Am So Mass Spectrom"},{"issue":"5","key":"40_CR239","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s10719-017-9790-7","volume":"34","author":"G Li","year":"2017","unstructured":"Li G, Li L, Joo EJ, Son JW, Kim YJ, Kang JK et al. (2017) Glycosaminoglycans and glycolipids as potential biomarkers in lung cancer. Glycoconj J 34(5):661\u2013669","journal-title":"Glycoconj J"},{"issue":"3","key":"40_CR240","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/mas.10073","volume":"23","author":"J Zaia","year":"2004","unstructured":"Zaia J (2004) Mass spectrometry of oligosaccharides. Mass Spectrom Rev 23(3):161\u2013227","journal-title":"Mass Spectrom Rev"},{"key":"40_CR241","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/BF01049915","volume":"5","author":"B Domon","year":"1988","unstructured":"Domon B, Costello CE (1988) A systematic nomenclature of carbohydrate fragmentation in FAB-MS\/MS spectra of glycoconjugates. Glycoconj J 5:397\u2013409","journal-title":"Glycoconj J"},{"key":"40_CR242","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/1044-0305(92)87010-V","volume":"3","author":"Q Ann","year":"1992","unstructured":"Ann Q, Adams J (1992) Structure determination of ceramides and neutral glycosphingolipids by collisional activation of [M+Li]+ ions. J Am Soc Mass Spectrom 3:260\u2013263","journal-title":"J Am Soc Mass Spectrom"},{"key":"40_CR243","doi-asserted-by":"publisher","first-page":"113976","DOI":"10.1016\/j.ab.2020.113976","volume":"609","author":"R Ica","year":"2020","unstructured":"Ica R, Simulescu A, Sarbu M, Munteanu CVA, Vukeli\u0107 \u017d, Zamfir AD (2020) High-resolution mass spectrometry provides novel insights into the ganglioside pattern of brain cavernous hemangioma. Anal Biochem 609:113976","journal-title":"Anal Biochem"},{"key":"40_CR244","doi-asserted-by":"publisher","first-page":"7321","DOI":"10.1007\/s00216-013-7173-x","volume":"405","author":"AD Zamfir","year":"2013","unstructured":"Zamfir AD, Fabris D, Capitan F, Munteanu C, Vukeli\u0107 \u017d, Flangea C (2013) Profiling and sequence analysis of gangliosides in human astrocytoma by high-resolution mass spectrometry. Anal Bioanal Chem 405:7321\u20137335","journal-title":"Anal Bioanal Chem"},{"key":"40_CR245","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1002\/elps.201200044","volume":"33","author":"C Schiopu","year":"2012","unstructured":"Schiopu C, Vukeli\u0107 \u017d, Capitan F, Kalanj-Bognar S, Sisu E, Zamfir AD (2012) Chip-nanoelectrospray quadrupole time-of-flight tandem mass spectrometry of meningioma gangliosides: a preliminary study. Electrophoresis 33:1778\u20131786","journal-title":"Electrophoresis"},{"key":"40_CR246","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1093\/glycob\/cwm012","volume":"17","author":"\u017d Vukeli\u0107","year":"2007","unstructured":"Vukeli\u0107 \u017d, Kalanj-Bognar S, Froesch M, B\u00eendila L, Radi\u0107 B, Allen M et al. (2007) Human gliosarcoma-associated ganglioside composition is complex and distinctive as evidenced by high-performance mass spectrometric determination and structural characterization. Glycobiology 17:504\u2013515","journal-title":"Glycobiology"},{"issue":"9","key":"40_CR247","first-page":"3861","volume":"32","author":"GF Whalen","year":"2012","unstructured":"Whalen GF, Sullivan M, Piperdi B, Wasseff W, Galili U (2012) Cancer immunotherapy by intratumoral injection of \u03b1-gal glycolipids. Anticancer Res 32(9):3861\u20133868","journal-title":"Anticancer Res"}],"container-title":["Advances in Experimental Medicine and Biology","Advancements of Mass Spectrometry in Biomedical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-032-29437-1_40","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:52:00Z","timestamp":1792601520000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/chapter\/10.1007\/978-3-032-29437-1_40"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9783032294364","9783032294371"],"references-count":247,"URL":"https:\/\/doi.org\/10.1007\/978-3-032-29437-1_40","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"23 January 2027","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}